| Financial Year |
March 31 2023 |
| Monetary Funds |
682,321,159.57 |
| Held-for-trading Financial Assets |
42,533,440.19 |
| Notes Receivable |
-- |
| Accounts Receivable |
24,395,296.35 |
| Advances to Suppliers |
31,659,039.45 |
| Other Receivables |
21,321,758.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
302,097.26 |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
27,444,492.13 |
| Other Current Assets |
407,511,720.35 |
| Total Current Assets |
1,237,186,906.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
162,943,153.66 |
| Long-term Equity Investment |
24,491,371.98 |
| Investment Properties |
-- |
| Fixed Assetes |
4,777,103.49 |
| Under-construction Projects |
118,857,759.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,270,573.82 |
| R&D expenses |
-- |
| Goodwill |
8,160,185.67 |
| Long-Term Deferred and Prepaid Expenses |
783,338,110.89 |
| Deferred Income Tax Assets |
175,731,810.21 |
| Other Non-Current Assets |
138,013,185.60 |
| Sub-Total of Non-Current Assets |
4,889,828,415.91 |
| Total Assets |
6,127,015,322.03 |
| Short-Term Loans |
3,250,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
156,433,378.06 |
| Accounts Received In Advance |
124,445,041.16 |
| Employee Compensation Payable |
35,666,374.29 |
| Taxes Payable |
28,292,176.26 |
| Interest Payable |
52,389.85 |
| Dividend Payable |
-- |
| Other payables |
227,116,428.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
374,467,865.85 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
989,632,745.46 |
| Long-term Loans |
6,483,643.61 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,451,013.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,791,946,352.38 |
| Total Liabilities |
4,781,579,097.84 |
| Paid-In Capital(Or Share Stock) |
153,603,596.00 |
| Capital Surplus |
1,189,646,951.66 |
| Surplus Reserve |
28,002,846.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-78,227,083.43 |
| Minority Stockholder's Interest |
52,018,221.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,293,418,002.44 |
| Owner's Equity（Stockholder's Equity） |
1,345,436,224.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,127,015,322.03 |
